1 / 4

Plaque Psoriasis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

(Albany, US) DelveInsight has launched a new report on "Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030".<br>DelveInsight's "Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<br>Some of the contents:<br>u2022tAccording to National Psoriasis Foundation (NPF), more than 8 million Americans have psoriasis. Plaque psoriasis is the most common form of the disease, affecting 80 percent of those with psoriasis.<br>u2022tIn U.S., the prevalence of Psoriasis is estimated to be 0.6 to 4.8%.<br>u2022t125 million people worldwide which is about 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium.<br>u2022tAccording to Gulbahar S et al., about 90% of psoriasis cases is plaque psoriasis, which is characterized by "plaques", or raised, red areas of skin covered with a silver or white layer of scale.<br>u2022tPsoriasis is considered equally prevalent in both sexes. However, out of all studies that reported prevalence by sex in Global report of Psoriasis by World Health Organization, some of them indicate that psoriasis is more common in men. This issue needs further investigation.<br>View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market<br>

sthakur
Download Presentation

Plaque Psoriasis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Plaque Psoriasis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight (Albany, US) DelveInsight has launched a new report on "Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030". DelveInsight's "Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the contents: According to National Psoriasis Foundation (NPF), more than 8 million Americans have psoriasis. Plaque psoriasis is the most common form of the disease, affecting 80 percent of those with psoriasis. In U.S., the prevalence of Psoriasis is estimated to be 0.6 to 4.8%. 125 million people worldwide which is about 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium. According to Gulbahar S et al., about 90% of psoriasis cases is plaque psoriasis, which is characterized by "plaques", or raised, red areas of skin covered with a silver or white layer of scale. Psoriasis is considered equally prevalent in both sexes. However, out of all studies that reported prevalence by sex in Global report of Psoriasis by World Health Organization, some of them indicate that psoriasis is more common in men. This issue needs further investigation. View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market Request for free sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis- market Scope of the Report The report covers the descriptive overview of Plaque Psoriasis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies Comprehensive insight has been provided into the Plaque Psoriasis epidemiology and treatment in the 7MM Additionally, an all-inclusive account of both the current and emerging therapies for Plaque Psoriasis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape A detailed review of Plaque Psoriasis market; historical and forecasted is included in the report, covering drug outreach in the 7MM

  2. The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Plaque Psoriasis market View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market Request for free sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis- market Psoriasis is a common skin condition that speeds up the life cycle of skin cells. It causes cells to build up rapidly on the surface of the skin. The extra skin cells form scales and red patches that are itchy and sometimes painful. According to National Psoriasis Foundation (NPF), plaque psoriasis is the most common form of psoriasis and appears as raised, red patches covered with a silvery white buildup of dead skin cells. These patches or plaques most often show up on the scalp, knees, elbows and lower back. They are often itchy and painful, and they can crack and bleed. The characteristic signs and symptoms of psoriasis are small scaly, red bumps. These bumps generally join together into elevated plaques of skin and most often are visible on the elbows, knees, and scalp, although any area of skin can be involved. Frequently, these plaques are quite itchy. Rarely, most of the patient's skin surface is affected. Some of the Companies: Bristol-Myers Squibb Dermavant Sciences GmbH Arcutis, Inc. Avillion LLP And Many Others Drugs Covered: TAZORAC M1095 Tapinarof BMS-986165 And Many Others View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market Request for free sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis- market Table of Contents: 1. Key Insights 2. Executive Summary of Plaque Psoriasis 3. Competitive Intelligence Analysis for Plaque Psoriasis 4. Plaque Psoriasis: Market Overview at a Glance 4.1. Plaque Psoriasis Total Market Share (%) Distribution in 2017

  3. 4.2. Plaque Psoriasis Total Market Share (%) Distribution in 2030 5. Plaque Psoriasis: Disease Background and Overview 6. Patient Journey 7. Plaque Psoriasis Epidemiology and Patient Population 8. Treatment Algorithm, Current Treatment, and Medical Practices 8.1. Plaque Psoriasis Treatment and Management 8.2. Plaque Psoriasis Treatment Algorithm 9. Unmet Needs 10. Key Endpoints of Plaque Psoriasis Treatment 11. Marketed Products List to be continued in report 12. Emerging Therapies List to be continued in report 13. Plaque Psoriasis: Seven Major Market Analysis 13.1. Key Findings 13.2. Plaque Psoriasis Market Size in 7MM 13.3. Plaque Psoriasis Market Size by Therapies in the 7MM 14. Attribute analysis 15. 7MM: Market Outlook 16. Access and Reimbursement Overview of Plaque Psoriasis 17. KOL Views 18. Market Drivers 19. Market Barriers 20. Appendix 21. DelveInsight Capabilities 22. Disclaimer 23. About DelveInsight About DelveInsight DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for Browse through our vast repository from here.

  4. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Ankit Nigam Email: info@delveinsight.com Phone: +19193216187 City: Albany State: New York Country: United States Website: https://www.delveinsight.com/

More Related